Business · 17/06/2025Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting for REXULTI (brexpiprazole) Tablets
Summary
The FDA is hosting a public meeting of the Psychopharmacologic Drugs Advisory Committee to provide advice on the supplemental new drug application for REXULTI, and is seeking public comments on the matter.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →